Immunotherapy Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Immunotherapy Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Asthma Therapy
New asthma therapy study findings recently were reported by investigators at Medical Research Institute of New Zealand
April 11th, 2007
Fresh data on asthma are presented in the report "External validity of randomised controlled trials in asthma: to whom do the results of the trials apply." According to recent research published in the journal Thorax, "Asthma is a heterogeneous disease with a wide range of clinical phenotypes, not all of which may be encompassed in the subjects included in randomised controlled trials (RCTs). This makes it difficult for clinicians to know to what extent the evidence derived from RCTs applies to a given patient." "To calculate the proportion of individuals with asthma who would have been eligible for the major asthma RCTs from the data of a random community survey...
Source: Immunotherapy Weekly (2007-04-11)
|
